Lassila R - Search Results

1

Måseide RJ, Berntorp E, Astermark J, Olsson A, Bruzelius M, Frisk T, Nummi V, Lassila R, Tjønnfjord GE, Holme PA. Måseide RJ, et al. Among authors: lassila r. Haemophilia. 2024 Jan;30(1):98-105. doi: 10.1111/hae.14899. Epub 2023 Nov 20. Haemophilia. 2024. PMID: 37983883

2

Fundamentals for a Systematic Approach to Mild and Moderate Inherited Bleeding Disorders: An EHA Consensus Report.

Rodeghiero F, Pabinger I, Ragni M, Abdul-Kadir R, Berntorp E, Blanchette V, Bodó I, Casini A, Gresele P, Lassila R, Leebeek F, Lillicrap D, Mezzano D, Noris P, Srivastava A, Tosetto A, Windyga J, Zieger B, Makris M, Key N. Rodeghiero F, et al. Among authors: lassila r. Hemasphere. 2019 Sep 17;3(4):e286. doi: 10.1097/HS9.0000000000000286. eCollection 2019 Oct. Hemasphere. 2019. PMID: 31942541 Free PMC article. Review.

3

Characterisation of healthcare utilisation and cost of haemophilia care in real-life: A 4-year follow-up study in Finland.

Ventola H, Vesikansa A, Jokelainen J, Siitonen T, Ettala P, Laine O, Lehtinen E, Lepäntalo A, Patronen M, Partanen A, Linna M, Ylisaukko-Oja T, Lassila R. Ventola H, et al. Among authors: lassila r. Haemophilia. 2021 Jan;27(1):e30-e39. doi: 10.1111/hae.14197. Epub 2020 Nov 20. Haemophilia. 2021. PMID: 33216410

4

Do we need all that emicizumab?

Lehtinen AE, Lassila R. Lehtinen AE, et al. Among authors: lassila r. Haemophilia. 2022 Mar;28(2):e53-e55. doi: 10.1111/hae.14483. Epub 2021 Dec 30. Haemophilia. 2022. PMID: 34970820 No abstract available.

5

Platelet function testing: Current practice among clinical centres in Northern Europe.

Szanto T, Zetterberg E, Ramström S, Leinøe EB, Holme PA, Antovic JP, Holmström M, Onundarson PT, Pikta M, Vaide I, Olsson A, Magnusson M, Kärkkäinen S, Bitar M, Poulsen LH, Lassila R; Nordic Haemophilia Council. Szanto T, et al. Among authors: lassila r. Haemophilia. 2022 Jul;28(4):642-648. doi: 10.1111/hae.14578. Epub 2022 May 5. Haemophilia. 2022. PMID: 35510959 Free PMC article.

6

Switching from standard to extended half-life FVIII prophylaxis in haemophilia A: Comparison of factor product use, bleed rates and pharmacokinetics.

Nummi V, Lehtinen AE, Iorio A, Szanto T, Lassila R. Nummi V, et al. Among authors: lassila r. Haemophilia. 2022 Nov;28(6):e237-e244. doi: 10.1111/hae.14649. Epub 2022 Aug 8. Haemophilia. 2022. PMID: 35939628

7

No difference in quality of life between persons with severe haemophilia A and B.

Kihlberg K, Baghaei F, Bruzelius M, Funding E, Andre Holme P, Lassila R, Nummi V, Ranta S, Gretenkort Andersson N, Berntorp E, Astermark J. Kihlberg K, et al. Among authors: lassila r. Haemophilia. 2023 Jul;29(4):987-996. doi: 10.1111/hae.14759. Epub 2023 Feb 15. Haemophilia. 2023. PMID: 36791275

8

Challenges in ageing persons with haemophilia.

Makris M, Lassila R, Kennedy M. Makris M, et al. Among authors: lassila r. Haemophilia. 2024 Apr;30 Suppl 3:5-11. doi: 10.1111/hae.14994. Epub 2024 Mar 27. Haemophilia. 2024. PMID: 38539058

9

Total joint replacement in inhibitor-positive haemophilia: Long-term outcome analysis in fifteen patients.

Danielson H, Lassila R, Ylinen P, Yrjönen T. Danielson H, et al. Among authors: lassila r. World J Orthop. 2017 Oct 18;8(10):777-784. doi: 10.5312/wjo.v8.i10.777. eCollection 2017 Oct 18. World J Orthop. 2017. PMID: 29094008 Free PMC article.

10

COVID-19: another reason for anticoagulation in patients with atrial fibrillation.

Raatikainen P, Lassila R. Raatikainen P, et al. Among authors: lassila r. Heart. 2022 May 25;108(12):902-904. doi: 10.1136/heartjnl-2022-320845. Heart. 2022. PMID: 35314451 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

266 results

Search Page